A liquid chromatography-tandem mass spectrometry method is described for the blood determination of selective serotonin reuptake inhibitors (fluoxetine, paroxetine, sertraline, fluvoxamine, and citalopram), serotonin noradrenaline reuptake inhibitors (milnacipram and venlafaxine), a noradrenergic and specific serotoninergic antidepressant (mirtazapine) and five of their active metabolites (norfluoxetine, desmethylcitalopram, didesmethylcitalopranl, desmethylvenlafaxine, and desmethylmirtazapine). After a liquid-liquid extraction from blood, the compounds and the internal standard (methylrisperidone) were eluted on a XTerra | RP18 column with a gradient of acetonitrile/ammonium formate buffer 4 mmol/L pH 3.2. They were then detected by electrospray ionization mass spectrometry with multiple reaction monitoring mode.
Introduction
disorders because of their better-tolerated adverse effects in comparison with tricyclic antidepressant drugs (1) (2) (3) . However, they are frequently used in deliberate self-poisoning and they can lead to major intoxication (4) (5) (6) (7) (8) . Analysis of antidepressants could be also necessary in forensic cases such as driving under the influence of drugs, cases of violent crime, cases of drug-facilitated sexual assault and cases of unknown cause of death. Consequently, a specific analytical method may be indicated in clinical and forensic toxicology to screen and quantify these drugs in whole blood.
Some methods for the determination of several antidepressants, tricyclic and "new antidepressants", in biological samples have been described. They involve high-performance liquid chromatography (HPLC) with ultraviolet detection (9) (10) (11) , mass spectrometry (MS) (12, 13) or tandem MS (14, 15) , and gas chromatography with mass spectrometry (GC-MS) (16, 17) . However, none of these methods allows the simultaneous determination of SSRIs, SNaRls and mirtazapine by LC-MS-MS with liquid-liquid extraction.
We have previously developed a method for the determination of tricyclic antidepressants and MAOIs by LC-MS-MS in whole blood (18) . The aim of this study was to develop a LC-MS-MS method, adapted to routine application, allowing specific and sensitive determination of SSRIs, SNaRIs, mirtazapine (a noradrenergic and specific serotoninergic antidepressant), and five of their active metabolites (norfluoxetine, desmethylcitalopram, didesmethylcitalopram, desmethylvenlafaxine, and desmethylmirtazapine) for forensic toxicology.
Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenergic reuptake inhibitors (SNaRIs) are widely used for the treatment of depression and other psychiatric 
Standard solutions
The stock solutions were prepared by dissolving accurately weighed amount in methanol to yield a 1 mg/mL drug concentration. A 1 mg/mL stock solution of internal standard in methanol was prepared and further diluted 1:1000 in methanol to give a 1 IJg/mL working solution.
Routine daily calibration curves and controls were prepared for each analytical batch in drug-free whole blood. Calibration standards were made to yield concentrations of 5, 10, 25, 50, 100, 250, and 500 ng/mL [20, 40, 100, 200 , 400, 1000, and 2000 ng/mL for V and desmethylvenlafaxine (DV)]. For the preparation of quality controls (QC) used for the validation of the assay, an independent stock solution was prepared and further diluted, to achieve concentrations of 10, 80, and 400 ng/mL (40, 320, and 1600 ng/mL for V and DV).
Chromatography
The HPLC unit consisted of an Alliance | 2690 separation module (Waters, Milford, MA) controlled by the Masslynx | software. Separations were performed at 25~ on a XTerra RP18 100-x 2.l-ram column (Waters). The mobile phase consisted of a gradient of acetonitrile/ammonium formate buffer (4 mmol/L, pH 3.2). First, acetonitrile was set at 15% (v/v) for 1 rain; then itwas increased linearly to 35% over 12 rain and set at 35% for 1 min. The system was then set at the initial conditions in 30 s and was re-equilibrated over 2.5 rain before the next injection. The total run time of the analysis was 17 min at a flow rate of 0.3 mL/min.
MS
A QuattroMicro | triple quadrupole detector (Waters) with electrospray ionization (ESI) in positive ion mode was used for detection. The MS was operated in the multiple-reaction monitoring (MRM) mode.
The ESI source was operated at a temperature of 115~ The desolvation temperature was set at 280~ The cone gas flow was set at 50 L/h, and the desolvation gas flow was at 500 L/h. The capillary voltage was 3.2 kV. The cone voltages were optimized for each compound. The MS collision gas was argon at 2.96 x 10 -3 mbar, and the collision energies were optimized for each compound. Parent ions, the corresponding daughter ions, retention times, cone voltages, collision energies, and dwell times optimized for each compound and the I.S. are presented in Table I .
Sample preparation
Whole blood (500 pL) was spiked with 100 pL of internal standard (1 pg/mL) To determine the adequate fit linear model, the difference between the observed values and the fitted y-values expressed as coefficient of variation (CV) was examined for each standard concentration. The CV should be less than 15% for each plot of all calibration curves (19) .
Precision. The precision of the developed method was determined by analysis of three quality control samples containing 10, 80, and 400 ng/mL (40, 320, and 1600 ng/mL of V and DV). Intraday variation of the assay was assessed by injecting four quality controls at each concentration on the same day. Interday variation was assessed by injecting a further four samples of each concentration on three subsequent days. Subsequently, the mean of each set of the concentrations, the standard deviation (SD), and coefficient of variation (CV) were determined. The precision expressed as CV should be less than 15% for each QC sample (19) .
Bias. Bias was measured as the percentage of difference from theoretical concentration according to the equation:
The bias should be less than 15% for all QC samples (19) . Limit of quantification. The limit of quantification (LOQ) was determined as the lowest concentration of a given drug giving a response that could be quantified with both interassay variation and bias lower than 20%. Extraction recovery. Extraction recovery from human whole blood was determined by comparing the response of extracts with the drug added before extraction against extracts with the drug added after extraction. Two quality control samples, containing 80 and 400 ng/mL of each compound (320 and 1600 ng/mL of V and DV), were analyzed four times.
Specificity. The lack of interference from endogenous blood compounds was examined by analyzing different blank human blood extracts with or without internal standard. Three different blank human blood samples from hospitalised patients were tested to check for the lack of interferences with each drug and the internal standard.
The lack of interference from each drug and internal standard to the MRM channels of the other drugs was checked by injecting pure solutions of each drug separately and searching for the total absence of signal in the MRM channels of the other drugs. 
Results

Chromatography
A representative chromatogram of a blood sample spiked with 50 ng/mL of each drug is presented in Figures 1 and 2 . Under the described chromatographic conditions, all compounds were separated in 17 rain.
tinearity, precision, bias, and recovery
Calibration curves were linear in the range 5-500 ng/mL (20-2000 ng/mL for V and DV) (r 2 > 0.995) with a slope variation coefficient (n = 3) lower than 12%.
The results obtained for precision and bias are presented in Table II . The method showed intraday and interday precision, expressed as CV, of less than 10%. A bias of less than 12% was achieved. The lower limit of quantification, determined as the lowest concentration of a given drug giving a response that could be quantified with both interassay variation and bias lower than 20%, was 5 ng/mL (20 ng/mL for V and its metabolite).
The extraction recoveries obtained at the different tested concentrations are presented in Table III . The extraction recoveries were between 70 and 90% except for desmethylmirtazapine, DV, milnacipram, and didesmethylminalcipram.
Specificity
As shown in Figure 3 , no interference was seen from endogenous substances in drug-free human blood at the times of interest. Figures 4 and 5 show the lack of interference from the internal standard to the MRM channels of the drugs.
Ion suppression
The ion suppression assay did not show any significant reduction in the response of each drug. As shown in Table III , the relative recoveries were more than 80%. No matrix effect was observed.
Discussion
cally used for classical reversed-phase HPLC methods, we did not see any unusually rapid degradation of column performance, so this method is adapted to routine application and can be used easily in clinical practice.
The present method showed good intra-assay precision and accuracy for all compounds, with CV values lower than 10% and bias lower than 12% (Table II) . The LOQ (5 ng/mL or 20 ng/mL for V and DV) and calibration range (5 to 500 ng/mL or 20 to 2000 ng/mL for V and DV) of the assay make our method convenient for analysis of antidepressants in case of unknown cause of death but also in cases of chemical abuse. Linearity was evaluated using a weighted least squares linear regression model except for V and DV, a weighted least squares quadratic regression model was used. For these molecules, both linear and quadratic regression models were evaluated. However, the quadratic model provided a better fit in the range 20-2000 ng/mL (Figures 6 and 7) . The correlation coefficient r 2 was always higher than 0.995. Furthermore, the CV for each plot of all calibration curves is less than 12%, and the low values were less underestimated.
In case of intoxication, concentrations higher than 500 ng/mL (2000 ng/mL for V and DV) could be found, and therefore, samples must be diluted with blank whole blood. To validate the dilution with blank matrix, a quality control sample containing 1000 ng/mL (4000 ng/mL for V and DV) was diluted 1:10 in triplicates. The bias was lower than 15% (data not shown).
The present assay is used routinely in our laboratory. As an example, we describe the case of a woman who was found dead in her residence by her husband. Deliberate self-poisoning was suspected. First, a general drug screening by GC-MS and LC with diode-array detection was carried out on the cardiac blood and revealed the presence of olanzapine, alprazolam, zolpidem, citalopram, and viloxazine. No alcohol was detected. Therefore, a quantitative analysis of citalopram and the other drugs was carried out on the peripheral blood. The concentrations were 6920 ng/mL for citalopram, 170 ng/mL for desmethylcitalopram, and 18 ng/mL for didesmethylcitalopram. For citalopram, the sample was diluted 1:20 (v/v) and analyzed again. The chromatogram is shown in Figure 8 .
The method presented here allows the specific and sensitive determination of SSRIs, SNaRIs, and mirtazapine (a noradrenergic and specific serotoninergic antidepressant) and five of their active metabolites. To our knowledge, this is the first method reported in the literature for screen and quantify all these drugs simultaneously, in whole blood by LC-MS-MS with a liquid-liquid extraction. LC-MS-MS enables laboratories to perform analyses with the sensitivity and specificity required for forensic toxicology.
We chose to use a liquid-liquid extraction instead of a precipitation (15) to reduce matrix effect (20, 21) . Moreover, liquid-liquid extraction is easily available in all laboratories, unlike automated solid-phase extraction or turbulent flow chromatography, which require instruments available only in a few laboratories. Although we injected samples from HCI (0.05N), which is far more aggressive than the solvents typi-
